Fadia T. Shaya, PhD, MPH

Articles by Fadia T. Shaya, PhD, MPH

Patient-Centered Teamwork in Care Transitions

ByNiharika Khanna, MD, MBBS, DGO,Fadia T. Shaya, PhD, MPH,Viktor V. Chirikov, MS,David Sharp, PhD,Ben Steffen, MA

June 12th 2015

Physician-led patient care teams have the potential to impact care transitions to prevent fragmentation of care, and ensure seamless care delivery.

Disease-Modifying Therapy and Hospitalization Risk in Heart Failure Patients

ByFadia T. Shaya, PhD, MPH,Ian M. Breunig, PhD,Mandeep R. Mehra, MD, FACC, FACP, FRCP

January 20th 2015

Substantive outcome improvement and savings to Medicaid may be achieved with small changes in prescribing rates or comorbidity prevalence among patients with heart failure.

Decision Support Tools to Optimize Economic Outcomes for Type 2 Diabetes

ByFadia T. Shaya, PhD, MPH,Viktor V. Chirikov, MS

November 11th 2011

Quantifying the Role of Natalizumab in Health and Economic Outcomes in Multiple Sclerosis

ByDavid W. Brandes, MS, MD, FAAN,Fadia T. Shaya, PhD, MPH,Michael W. Pill, PharmD

June 24th 2010

Effect of Medication Burden on Persistent Use of Lipid-Lowering Drugs Among Patients With Hypertension

ByTeisha A. Robertson, PharmD, MBA,Catherine E. Cooke, PharmD, BCPS,Jingshu Wang, PhD,Fadia T. Shaya, PhD, MPH,Helen Y. Lee, PharmD, MBA

November 14th 2008

This study assesses the effect of medication burden on persistent use of newly added lipid-lowering drugs among patients with hypertension.

Drug Therapy Persistence and Stroke Recurrence

ByFadia T. Shaya, PhD, MPH,Antoine C. El Khoury, PhD,C. Daniel Mullins, PhD,Dongyi Du, MSc,Richard Skolasky, MA,Hugh Fatodu, RPh,Howard Garber, MD, MPH,Matthew R. Weir, MD

June 1st 2006

Persistence With Overactive Bladder Pharmacotherapy in a Medicaid Population

ByFadia T. Shaya, PhD, MPH,Steven Blume, MS,Anna Gu, MA,Teresa Zyczynski, PharmD, MBA, MPH,Zhanna Jumadilova, MD, MBA

July 15th 2005

Dicontinuation Rates of Topical Glaucoma Medications in a Managed Care Population

ByFadia T. Shaya, PhD, MPH,C. Daniel Mullins, PhD,Winston Wong, PharmD,Jeannie Cho, PharmD

August 1st 2002

Latest Updated Articles

Disease-Modifying Therapy and Hospitalization Risk in Heart Failure Patients
January 20th 2015
Patient-Centered Teamwork in Care Transitions
June 12th 2015
Drug Therapy Persistence and Stroke Recurrence
June 1st 2006
Persistence With Overactive Bladder Pharmacotherapy in a Medicaid Population
July 15th 2005
Dicontinuation Rates of Topical Glaucoma Medications in a Managed Care Population
August 1st 2002
Quantifying the Role of Natalizumab in Health and Economic Outcomes in Multiple Sclerosis
June 24th 2010

Fadia T. Shaya, PhD, MPH

Articles by Fadia T. Shaya, PhD, MPH

Patient-Centered Teamwork in Care Transitions

Disease-Modifying Therapy and Hospitalization Risk in Heart Failure Patients

Decision Support Tools to Optimize Economic Outcomes for Type 2 Diabetes

Quantifying the Role of Natalizumab in Health and Economic Outcomes in Multiple Sclerosis

Effect of Medication Burden on Persistent Use of Lipid-Lowering Drugs Among Patients With Hypertension

Drug Therapy Persistence and Stroke Recurrence

Persistence With Overactive Bladder Pharmacotherapy in a Medicaid Population

Dicontinuation Rates of Topical Glaucoma Medications in a Managed Care Population

Latest Updated Articles

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access